Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.Withdrawn
NCT02019290Phase 1Updated Oct 25, 2017
Sponsor: Hoffmann-La Roche
Healthy Volunteer
Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down SyndromeCompleted
NCT02451657N/AUpdated Oct 25, 2017
Sponsor: Hoffmann-La Roche
Down Syndrome
United States, France, Spain
A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)Completed
NCT02024789Phase 2Updated Oct 25, 2017
Sponsor: Hoffmann-La Roche
Down Syndrome
United States, Argentina, Canada, France, Italy +5 more
Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis ConditionCompleted
NCT02598167N/AUpdated Oct 25, 2017
Sponsor: Hoffmann-La Roche
Multiple Sclerosis, Relapsing-Remitting
Spain
A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)Completed
NCT02133508N/AUpdated Oct 24, 2017
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
Italy
An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerTerminated
NCT01187381N/AUpdated Oct 20, 2017
Sponsor: Hoffmann-La Roche
Breast Cancer
Romania
Rituximab in Auto-Immune Hemolytic AnemiaCompleted
NCT01181154Phase 3Updated Oct 19, 2017
Sponsor: Assistance Publique - Hôpitaux de Paris
Warm Autoimmune Hemolytic Anemia
France
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell LymphomaCompleted
NCT01649856Phase 3Updated Oct 11, 2017
Sponsor: Hoffmann-La Roche
Lymphoma, Large B-Cell, Diffuse
Algeria, Argentina, Belgium, Brazil, Bulgaria +22 more
Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)Unknown
NCT00407186Phase 3Updated Oct 10, 2017
Sponsor: Dutch Colorectal Cancer Group
Gastric Cancer
Netherlands
An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell CarcinomaCompleted
NCT01351571N/AUpdated Oct 4, 2017
Sponsor: Hoffmann-La Roche
Renal Cell Cancer
India
A Study of Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow ResponseCompleted
NCT01033448Phase 4Updated Oct 3, 2017
Sponsor: Hoffmann-La Roche
Hepatitis C, Chronic
Israel
A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis CCompleted
NCT01659567N/AUpdated Oct 3, 2017
Sponsor: Hoffmann-La Roche
Hepatitis C, Chronic
Georgia
APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and RibavirinCompleted
NCT02850289N/AUpdated Oct 3, 2017
Sponsor: Hoffmann-La Roche
Hepatitis C, Chronic
Canada
A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic DermatitisCompleted
NCT02340234Phase 2Updated Oct 2, 2017
Sponsor: Hoffmann-La Roche
Atopic Dermatitis
United States, Australia, Canada, Czechia, Finland +9 more
A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell CarcinomasCompleted
NCT01815840Phase 2Updated Sep 28, 2017
Sponsor: Hoffmann-La Roche
Basal Cell Carcinoma
United States, Austria, Canada, France, Germany +5 more
An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast CancerCompleted
NCT02286362N/AUpdated Sep 27, 2017
Sponsor: Hoffmann-La Roche
Breast Cancer
France
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed GlioblastomaCompleted
NCT00943826Phase 3Updated Sep 25, 2017
Sponsor: Hoffmann-La Roche
Glioblastoma
United States, Australia, Belgium, Canada, Denmark +19 more
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal CancerTerminated
NCT01765582Phase 2Updated Sep 18, 2017
Sponsor: Hoffmann-La Roche
Colorectal Neoplasms
United States
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)Completed
NCT01351415Phase 3Updated Sep 18, 2017
Sponsor: Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer
United States, Argentina, Austria, Belgium, Brazil +13 more
Lung Cancer Early Molecular Assessment TrialUnknown
NCT02894853N/AUpdated Sep 14, 2017
Sponsor: The Netherlands Cancer Institute
Carcinoma, Non-Small-Cell Lung
Netherlands
Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK PopulationWithdrawn
NCT02542436N/AUpdated Sep 13, 2017
Sponsor: Hoffmann-La Roche
Metastatic Colorectal Cancer
A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 ProteinCompleted
NCT01918254Phase 1Updated Sep 12, 2017
Sponsor: Hoffmann-La Roche
Breast Cancer
Denmark, France, Germany, Spain
ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating MutationsCompleted
NCT01723878N/AUpdated Sep 11, 2017
Sponsor: Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer
Spain
Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on HemodialysisCompleted
NCT00717366Phase 2Updated Sep 8, 2017
Sponsor: Hoffmann-La Roche
Renal Anemia
Australia, Belgium, France, Germany, Hungary +7 more
Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult SubjectsCompleted
NCT02145234Phase 1Updated Sep 7, 2017
Sponsor: Hoffmann-La Roche
Healthy Adults
United States

Previous page Next page